sometimes increases in HDL Liver : Improvements in fatty liver disease (reduced liver fat, improved liver enzymes) Cardiovascular Improvements : Blood Pressure : Significant reductions in systolic and diastolic blood pressure Cardiovascular Events : According to SELECT trial (semaglutide), 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) Heart Function : Improvements in cardiac structure and function markers Physical Function Improvements : Mobility : Improved ability to walk, climb stairs, engage in physical activities Joint Pain : Reduced knee, hip, and back pain from decreased weight-bearing stress Sleep : Improvements in sleep quality
Epub 2012 Feb 29
Heraa Chaudhry, MD, is a board-certified family medicine physician with more than a decade of clinical experience, specializing in preventative medicine, womens health, and integrative wellness
Tirzepatide: Weight Loss: Clinical trials have shown that Tirzepatide can lead to weight loss of up to 20-25% of initial body weight, making it a strong competitor against Semaglutide
Dutta D, Bhattacharya S, Surana V, et al